Belpointe Asset Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VPM
VCM
AM
FAM
Belpointe Asset Management's ALAB Position: Q1 2026 in Review
Belpointe Asset Management reduced its Astera Labs (ALAB) stake by 40% in Q1 2026, selling an estimated $1.03M and leaving 10,949 shares worth $1.2M. The position accounts for 0.04% of the portfolio, ranked #389.
Belpointe Asset Management first reported a position in ALAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.02M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.
- Belpointe Asset Management held 10,949 shares of Astera Labs worth $1.2M as of Q1 2026.
- Belpointe Asset Management sold 7,207 Astera Labs shares in Q1 2026, an estimated $1.03M.
- Astera Labs made up 0.04% of Belpointe Asset Management's portfolio in Q1 2026, its #389 holding.
- Belpointe Asset Management first reported a position in Astera Labs in Q2 2025 and has held it in 4 quarters since.
- Belpointe Asset Management's Astera Labs position peaked at $3.02M in Q4 2025.
- 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.